Cite Filings / CPIX / 0000950170-25-072872

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2025-05-15 Acc 0000950170-25-072872

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-09 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-09 4 Director bought 93 shares at an average $4.48 ($417)
2025-05-09 4 Director bought 186 shares at an average $4.48 ($833)
2025-05-09 4 Chairman and CEO bought 186 shares at an average $4.48 ($833)
2025-05-09 4 Director bought 1,035 shares at an average $4.48 ($4,635)
2025-02-13 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…